Nothing Special   »   [go: up one dir, main page]

IT8003429A0 - Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica - Google Patents

Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Info

Publication number
IT8003429A0
IT8003429A0 IT8003429A IT342980A IT8003429A0 IT 8003429 A0 IT8003429 A0 IT 8003429A0 IT 8003429 A IT8003429 A IT 8003429A IT 342980 A IT342980 A IT 342980A IT 8003429 A0 IT8003429 A0 IT 8003429A0
Authority
IT
Italy
Prior art keywords
riphamic
imidazo
substance
preparation
antibacterial action
Prior art date
Application number
IT8003429A
Other languages
English (en)
Other versions
IT1154655B (it
Inventor
Egidio Marchi Lauret Montecchi
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of IT8003429A0 publication Critical patent/IT8003429A0/it
Priority to IT03429/80A priority Critical patent/IT1154655B/it
Priority to US06/262,123 priority patent/US4341785A/en
Priority to NLAANVRAGE8102290,A priority patent/NL187022C/xx
Priority to AU70655/81A priority patent/AU537093B2/en
Priority to AT0222781A priority patent/AT373599B/de
Priority to FR8110058A priority patent/FR2482967A1/fr
Priority to EG280/81A priority patent/EG14891A/xx
Priority to PT73064A priority patent/PT73064B/pt
Priority to LU83376A priority patent/LU83376A1/fr
Priority to PH25656A priority patent/PH17207A/en
Priority to GR65010A priority patent/GR75640B/el
Priority to BE2/59169A priority patent/BE888895A/fr
Priority to ZA00813430A priority patent/ZA813430B/xx
Priority to FI811565A priority patent/FI69467C/fi
Priority to ES502906A priority patent/ES8203388A1/es
Priority to NO811731A priority patent/NO155622C/no
Priority to SE8103216A priority patent/SE453089B/sv
Priority to DK224781A priority patent/DK157876C/da
Priority to CA000378015A priority patent/CA1142518A/en
Priority to IE1139/81A priority patent/IE51204B1/en
Priority to AR285424A priority patent/AR226212A1/es
Priority to DE19813120460 priority patent/DE3120460A1/de
Priority to CH3381/81A priority patent/CH648037A5/de
Priority to JP7787781A priority patent/JPS5711987A/ja
Priority to GB8115790A priority patent/GB2079270B/en
Priority to PH26842A priority patent/PH18704A/en
Application granted granted Critical
Publication of IT1154655B publication Critical patent/IT1154655B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT03429/80A 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica IT1154655B (it)

Priority Applications (26)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
US06/262,123 US4341785A (en) 1980-05-22 1981-05-11 Imidazo-rifamycin derivatives with antibacterial utility
NLAANVRAGE8102290,A NL187022C (nl) 1980-05-22 1981-05-11 Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat.
AU70655/81A AU537093B2 (en) 1980-05-22 1981-05-18 New imidazo-rifamycin derivatives with antibacterial utility
AT0222781A AT373599B (de) 1980-05-22 1981-05-19 Verfahren zur herstellung neuer rifamycinderivate
FR8110058A FR2482967A1 (fr) 1980-05-22 1981-05-20 Nouveaux derives de l'imidazo-rifamycine, leur procede de preparation et leur application en therapeutique
EG280/81A EG14891A (en) 1980-05-22 1981-05-20 A process for preparation of derivatives of imiadozo-new rifamicyn have process antibacterial utility
PT73064A PT73064B (en) 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with anti-bacterial utility
LU83376A LU83376A1 (fr) 1980-05-22 1981-05-20 Nouveaux derives d'imidazo-rifamycine a activite antibacterienne
PH25656A PH17207A (en) 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with antibacterial utility
GR65010A GR75640B (it) 1980-05-22 1981-05-20
ZA00813430A ZA813430B (en) 1980-05-22 1981-05-21 New imidazo-rifamycin derivatives with antibacterial utility
BE2/59169A BE888895A (fr) 1980-05-22 1981-05-21 Nouveaux derives d'imidazo-rifamycine a activite antibacterienne
FI811565A FI69467C (fi) 1980-05-22 1981-05-21 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara pyrido- och isokinolin(1',2':1,2)imidazo(5,4-c)rifamycin soch sv-derivat
ES502906A ES8203388A1 (es) 1980-05-22 1981-05-21 Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
NO811731A NO155622C (no) 1980-05-22 1981-05-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido- og isokinolin (1[,2[:1,2) imidazo (5,4-c) rifamycin sv og s derivater.
SE8103216A SE453089B (sv) 1980-05-22 1981-05-21 Imidazo-rifamycinderivat, forfarande for framstellning derav och farmaceutisk komposition
DK224781A DK157876C (da) 1980-05-22 1981-05-21 Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
CA000378015A CA1142518A (en) 1980-05-22 1981-05-21 Imidazo-rifamycin derivatives with antibacterial utility
IE1139/81A IE51204B1 (en) 1980-05-22 1981-05-21 Imidazo-rifamycin derivatives
AR285424A AR226212A1 (es) 1980-05-22 1981-05-22 Procedimiento para preparar nuevos derivados de imidazo rifamicina
DE19813120460 DE3120460A1 (de) 1980-05-22 1981-05-22 Pyridoimidazolorifamycinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH3381/81A CH648037A5 (de) 1980-05-22 1981-05-22 Imidazo-rifamycin-derivate mit antibakterieller wirksamkeit.
JP7787781A JPS5711987A (en) 1980-05-22 1981-05-22 Novel imidazo-rifamycin derivative
GB8115790A GB2079270B (en) 1980-05-22 1981-05-22 Imidazo-rifamycin derivatives
PH26842A PH18704A (en) 1980-05-22 1982-02-09 Method of treatment using inidazo-rifamycin derivatives with antibacterial utility

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Publications (2)

Publication Number Publication Date
IT8003429A0 true IT8003429A0 (it) 1980-05-22
IT1154655B IT1154655B (it) 1987-01-21

Family

ID=11107198

Family Applications (1)

Application Number Title Priority Date Filing Date
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Country Status (25)

Country Link
US (1) US4341785A (it)
JP (1) JPS5711987A (it)
AR (1) AR226212A1 (it)
AT (1) AT373599B (it)
AU (1) AU537093B2 (it)
BE (1) BE888895A (it)
CA (1) CA1142518A (it)
CH (1) CH648037A5 (it)
DE (1) DE3120460A1 (it)
DK (1) DK157876C (it)
EG (1) EG14891A (it)
ES (1) ES8203388A1 (it)
FI (1) FI69467C (it)
FR (1) FR2482967A1 (it)
GB (1) GB2079270B (it)
GR (1) GR75640B (it)
IE (1) IE51204B1 (it)
IT (1) IT1154655B (it)
LU (1) LU83376A1 (it)
NL (1) NL187022C (it)
NO (1) NO155622C (it)
PH (2) PH17207A (it)
PT (1) PT73064B (it)
SE (1) SE453089B (it)
ZA (1) ZA813430B (it)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199374B (it) * 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
TW534813B (en) * 1997-02-28 2003-06-01 Kaneka Corp Treating agent for diseases due to infection with helicobacter
JP2005510534A (ja) * 2001-11-21 2005-04-21 アクティブバイオティクス インコーポレイティッド 標的化治療薬およびその使用
WO2003051299A2 (en) * 2001-12-13 2003-06-26 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
AU2003276254A1 (en) * 2002-11-05 2004-06-07 Piero Chiarelli Controlled and continued delivery of rifaximin and/or other substances
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
ITMI20032144A1 (it) 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7906542B2 (en) * 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7902206B2 (en) * 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7265107B2 (en) * 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7256187B2 (en) * 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
SI1698630T1 (sl) * 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US8404664B2 (en) 2005-08-11 2013-03-26 Targanta Therapeutics, Inc. Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections
MX2008011305A (es) 2006-03-09 2009-02-10 Salix Pharmaceuticals Inc Preparacion anti-disfunsion rectal con rifaximina.
HUE025306T2 (hu) 2006-08-02 2016-01-28 Salix Pharmaceuticals Inc Sugárterápia által okozott bélgyulladás kezelésére irányuló módszer
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
KR101480732B1 (ko) * 2006-09-22 2015-01-21 씨아이피엘에이 엘티디. 리팍시민
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
WO2009008005A1 (en) 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions of rifaximin
EP2011486B2 (en) 2007-07-06 2015-08-12 Lupin Ltd. Pharmaceutical compositions of rifaximin
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
CA2716830C (en) * 2008-02-25 2019-01-08 Salix Pharmaceuticals, Ltd. Forms of rifaximin and uses thereof
US8486956B2 (en) 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
RU2519649C2 (ru) 2008-02-26 2014-06-20 Саликс Фармасьютикалз, Лтд. Способы лечения заболеваний кишечника
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
WO2009137672A1 (en) 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
EP2324041A4 (en) 2008-08-13 2012-06-13 Targanta Therapeutics Corp PHOSPHONIZED RIFAMYCINS AND ITS APPLICATION FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
BRPI0918997A2 (pt) 2008-09-26 2015-12-01 Aska Pharm Co Ltd agente para evitar e/ou tratar um disturbio gastrointestinal funcional.
DK3628319T3 (da) 2008-10-02 2024-03-04 Salix Pharmaceuticals Ltd Behandling af hepatisk encefalopati ved anvendelse af rifaximin
KR101906177B1 (ko) 2008-12-10 2018-10-10 시플라 리미티드 리팍시민 복합체
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
KR20120025578A (ko) 2009-06-02 2012-03-15 샐릭스 파마슈티컬스 리미티드 간성 뇌병증의 치료방법
BR112012005627A2 (pt) 2009-09-13 2017-02-21 Salix Pharmaceuticals Ltd "uso de rifaximina para preparação de um medicamento para tratar síndrome do intestino irritável (ibs)"
UA110199C2 (xx) 2009-10-27 2015-12-10 Lupin Ltd Тверда дисперсія рифаксиміну
MX2012005883A (es) 2009-11-23 2012-10-09 Cipla Ltd Composicion topica en espuma.
WO2011080691A1 (en) 2009-12-28 2011-07-07 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
JP5896380B2 (ja) 2010-02-18 2016-03-30 サリックス ファーマスーティカルズ，リミテッド 感染症を治療するための方法
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
JP6092629B2 (ja) 2010-03-10 2017-03-08 ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ リファキシミン使用準備済懸濁液
AU2011279261B2 (en) 2010-07-12 2016-03-31 Salix Pharmaceuticals, Ltd. Formulations of rifaximin and uses thereof
US8759513B2 (en) 2010-09-13 2014-06-24 Sequent Scientific Limited Polymorphic form of rifaximin and process for its preparation
SG192122A1 (en) 2011-02-11 2013-08-30 Salix Pharmaceuticals Ltd Forms of rifaximin and uses thereof
AU2012251385A1 (en) 2011-05-02 2013-11-21 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
ITMI20110890A1 (it) * 2011-05-19 2012-11-20 A M S A Anonima Materie Sint & Affini S P A Polimorfo di rifaximina e processo per la sua preparazione
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
CA2854380A1 (en) 2011-11-02 2013-05-10 Salix Pharmaceuticals, Ltd. Methods for treating irritable bowel syndrome (ibs) and infections
JP2015509105A (ja) 2012-01-25 2015-03-26 サリックス ファーマスーティカルズ，リミテッド リファキシミン誘導体及びその使用
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
US9849090B2 (en) 2012-12-12 2017-12-26 Sun Pharmaceutical Industries Limited Pharmaceutical compositions of rifaximin
US20160047819A1 (en) 2013-03-15 2016-02-18 Alfa Wassermann S.P.A. Method for diagnosing vaginal infections
EA201591267A1 (ru) 2013-03-15 2016-03-31 Альфа Вассерманн С.П.А. Рифаксимин для применения в лечении вагинальных инфекций
EA032705B1 (ru) 2013-04-12 2019-07-31 Альфасигма С.П.А. Способ лечения или предупреждения энтеропатии
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
US9765088B2 (en) * 2014-04-19 2017-09-19 Granules India Limited Process for the preparation of rifamycin derivatives
MX2016014329A (es) 2014-05-04 2017-02-23 Salix Pharmaceuticals Inc Microbiota ibs y sus usos.
KR102362719B1 (ko) 2014-05-12 2022-02-14 알파시그마 에스.피.에이. 리팍시민의 신규한 용매화 결정 형태, 생산물, 조성물 및 이의 용도
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
CA3038312A1 (en) 2016-09-30 2018-04-05 Salix Pharmaceuticals, Inc. Solid dispersion forms of rifaximin
IT201700091912A1 (it) * 2017-08-08 2019-02-08 Biofer Spa Nuove pirido-imidazo rifamicine
RU2020102511A (ru) 2017-06-26 2021-07-27 Биофер С.П.А. Соединения пиридо-имидазо рифамицина в качестве антибактериального средства

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE273377C (it) *
AT273377B (de) * 1967-03-01 1969-08-11 Lepetit Spa Verfahren zur Herstellung von neuen Rifamycinen
AT344898B (de) * 1975-06-13 1978-08-10 Archifar Ind Chim Trentino Verfahren zur herstellung neuer rifamycin-verbindungen
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
CH629212A5 (it) * 1976-10-18 1982-04-15 Erba Farmitalia Procedimento per la preparazione di composti di rifamicina.
CH633014A5 (en) * 1978-06-09 1982-11-15 Erba Farmitalia Rifamycin compounds

Also Published As

Publication number Publication date
DE3120460A1 (de) 1982-03-11
ES502906A0 (es) 1982-04-01
LU83376A1 (fr) 1981-09-11
DK224781A (da) 1981-11-23
JPS5711987A (en) 1982-01-21
GB2079270A (en) 1982-01-20
SE453089B (sv) 1988-01-11
PT73064B (en) 1982-07-05
SE8103216L (sv) 1981-11-23
NL187022C (nl) 1991-05-01
AR226212A1 (es) 1982-06-15
PT73064A (en) 1981-06-01
ZA813430B (en) 1982-06-30
GB2079270B (en) 1984-01-18
DE3120460C2 (it) 1990-12-13
PH17207A (en) 1984-06-19
NO811731L (no) 1981-11-23
JPS6123192B2 (it) 1986-06-04
BE888895A (fr) 1981-09-16
NL187022B (nl) 1990-12-03
GR75640B (it) 1984-08-02
NO155622C (no) 1987-04-29
NO155622B (no) 1987-01-19
US4341785A (en) 1982-07-27
CH648037A5 (de) 1985-02-28
CA1142518A (en) 1983-03-08
IE811139L (en) 1981-11-22
ATA222781A (de) 1983-06-15
FR2482967B1 (it) 1985-03-29
FR2482967A1 (fr) 1981-11-27
IT1154655B (it) 1987-01-21
FI69467C (fi) 1986-02-10
FI811565L (fi) 1981-11-23
ES8203388A1 (es) 1982-04-01
NL8102290A (nl) 1981-12-16
IE51204B1 (en) 1986-10-29
DK157876B (da) 1990-02-26
FI69467B (fi) 1985-10-31
AU7065581A (en) 1981-11-26
AU537093B2 (en) 1984-06-07
PH18704A (en) 1985-09-05
DK157876C (da) 1990-07-30
AT373599B (de) 1984-02-10
EG14891A (en) 1985-12-31

Similar Documents

Publication Publication Date Title
IT8003429A0 (it) Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
IT1119284B (it) Derivati carbostirilici e procedimento per la loro preparazione
BR8107866A (pt) Derivados de 1-sulfo-2-oxoazetidina,sua producao e uso
IT1141057B (it) Derivati di deformiltilosina e loro preparazione
IT8222769A0 (it) Composti tetrakisazo derivati e procedimenti per la loro preparazione ed uso
IT1130489B (it) Derivati chinonici particolarmente utili come medianti e procedimento per la loro preparazione
IT1123120B (it) Cefem derivati e procedimento per la loro preparazione
IT1164735B (it) Derivati adenosinici e procedimento per la loro preparazione
IT1164076B (it) Composti farmaceutici ad azione antiulcera e procedimento per la loro preparazione
IT7969010A0 (it) Derivati di benzotiepinici e procedimento per la loro preparazione
IT1165368B (it) Nuovi cefem derivati ad azione antimicrobica e procedimento per la loro preparazione
IT1132403B (it) Derivati di alovincamone e procedimento per la loro preparazione
IT1147741B (it) Derivati di idrossiammino eburnano e procedimento per la loro preparazione
IT1113203B (it) Derivati steroideo-spiro-ossazolidinonici sostituiti e procedimento per la loro preparazione
IT1143701B (it) Derivati aril-idrazonici,loro uso come pesticidi e loro preparazione
IT1132404B (it) Derivati di 10-alo-e-omoeburnano e procedimento per la loro preparazione
IT1127336B (it) Derivati della cefalosporina loro preparazione e loro impiego
IT1106130B (it) Derivati di 24-deidrovitamina d3 e loro preparazione
IT1169903B (it) Derivati epossicarbaciclinici, loro preparazione e loro uso
IT1174735B (it) Derivati di tunicamina di attivita antibatterica e loro metodo di preparazione
IT8303354A0 (it) Derivati carbomoil-rifamicinici,metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT8203360A0 (it) Nuovi derivati carbamoilrifamicinici, metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT8203626A0 (it) Nuovi derivati imidazorifamicinici, metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT1150799B (it) Cefem derivati e procedimento per la loro preparazione
IT8119566A0 (it) Derivati della prostaciclina,loro preparazione e impiego

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 46

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 46, 19920304; ALFA WASSERMANN S.P.A.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423